Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
4Eyu0fm9Hxr9F0kH